These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25044310)

  • 1. How (not) to inform patients about drug use: use and effects of negations in Dutch patient information leaflets.
    Burgers C; Beukeboom CJ; Sparks L; Diepeveen V
    Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):137-43. PubMed ID: 25044310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient information leaflets--helpful guidance or a source of confusion?
    Bjerrum L; Foged A
    Pharmacoepidemiol Drug Saf; 2003; 12(1):55-9. PubMed ID: 12616848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How the doc should (not) talk: when breaking bad news with negations influences patients' immediate responses and medical adherence intentions.
    Burgers C; Beukeboom CJ; Sparks L
    Patient Educ Couns; 2012 Nov; 89(2):267-73. PubMed ID: 22938871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of patient information leaflet and perceived impact of its use on medication adherence.
    Al Jeraisy M; Alshammari H; Albassam M; Al Aamer K; Abolfotouh MA
    BMC Public Health; 2023 Mar; 23(1):488. PubMed ID: 36918823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of patient information leaflets provided by a district general hospital by the Flesch and Flesch-Kincaid method.
    Williamson JM; Martin AG
    Int J Clin Pract; 2010 Dec; 64(13):1824-31. PubMed ID: 21070533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Readability of Dermatological Postoperative Patient Information Leaflets Across England.
    Hunt WT; McGrath EJ
    Dermatol Surg; 2016 Jun; 42(6):757-63. PubMed ID: 27176870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worth the paper they are printed on? Findings from an independent evaluation of the understandability of patient information leaflets for antiseizure medications.
    Noble AJ; Haddad S; Coleman N; Marson AG
    Epilepsia; 2022 Aug; 63(8):2130-2143. PubMed ID: 35560228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of patient information leaflets incorporating patient diversity considerations: Varicocele embolisation and fluoroscopy guided joint injection examinations.
    Vassallo T; Mizzi A; Depasquale R; Maher M; Rainford L
    Radiography (Lond); 2018 Oct; 24 Suppl 1():S20-S27. PubMed ID: 30166004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABOP, the automatic patient information leaflet optimizer: evaluation of a tool in development.
    Franck MC; Foulon V; Van Vaerenbergh L
    Patient Educ Couns; 2011 Jun; 83(3):411-6. PubMed ID: 21621946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient information leaflets (PILs) for UK randomised controlled trials: a feasibility study exploring whether they contain information to support decision making about trial participation.
    Gillies K; Huang W; Skea Z; Brehaut J; Cotton S
    Trials; 2014 Feb; 15():62. PubMed ID: 24548781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication information leaflets for patients: the further validation of an analytic linguistic framework.
    Clerehan R; Hirsh D; Buchbinder R
    Commun Med; 2009; 6(2):117-27. PubMed ID: 20635549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Prescription Drug Information Leaflets: Impact of Cognitive Effort and Patient Involvement on Prescription Medication Information Processing.
    Patel HK; Bapat SS; Bhansali AH; Sansgiry SS
    Ther Innov Regul Sci; 2018 Jan; 52(1):118-129. PubMed ID: 29714618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Information for oral and maxillofacial patients: can it be improved?
    Parvez H; Noorani MS; Pandis N; Cobourne MT; Seehra J
    Br J Oral Maxillofac Surg; 2019 Jun; 57(5):412-418. PubMed ID: 31054792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preference of patient information leaflets over standard drug monographs by patients prescribed hydrochlorothiazide, nifedipine and enalapril.
    Gossell-Williams M; Bennett O; Dias Y; Foster K; Houston M; Wright K; Fairclough Z
    West Indian Med J; 2012 Jun; 61(3):271-9. PubMed ID: 23155986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient information leaflets: informing or frightening? A focus group study exploring patients' emotional reactions and subsequent behavior towards package leaflets of commonly prescribed medications in family practices.
    Herber OR; Gies V; Schwappach D; Thürmann P; Wilm S
    BMC Fam Pract; 2014 Oct; 15():163. PubMed ID: 25277783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient information leaflets for antidepressants: are patients getting the information they need?
    Haw C; Stubbs J
    J Affect Disord; 2011 Jan; 128(1-2):165-70. PubMed ID: 20656359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient information leaflets for placebo-controlled surgical trials: a review of current practice and recommendations for developers.
    Cousins S; Huttman M; Blencowe N; Tsang C; Elliott D; Blazeby J; Beard DJ; Campbell MK; Gillies K
    Trials; 2024 May; 25(1):339. PubMed ID: 38778336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence-generated patient information leaflets: a comparison of contents according to British Association of Dermatologists standards.
    Verran C
    Clin Exp Dermatol; 2024 Jun; 49(7):711-714. PubMed ID: 38169318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocebo effects and participant information leaflets: evaluating information provided on adverse effects in UK clinical trials.
    Kirby N; Shepherd V; Howick J; Betteridge S; Hood K
    Trials; 2020 Jul; 21(1):658. PubMed ID: 32680561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When describing harms and benefits to potential trial participants, participant information leaflets are inadequate.
    Cuddihy L; Howick J; Murphy E; Shiely F
    Trials; 2024 May; 25(1):292. PubMed ID: 38693579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.